ESC 365 - Which patients can benefit from advances in leadless pacemaker therapy beyond current guidelines?

Open Access

Which patients can benefit from advances in leadless pacemaker therapy beyond current guidelines?

Session: A new era in leadless pacing: a path to a new standard of care?

Topic: Antibradycardia Pacing

Speaker: Professor J. Kuschyk (Mannheim, DE)

Sponsored by Abbott

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Professor Juergen Kuschyk

University Medical Centre of Mannheim, Mannheim (Germany)

9 presentations

0 follower

4 more presentations in this session

Setting the stage

Speaker: Professor R. Knops (Amsterdam, NL)

Why choose leadless over transvenous pacemakers?

Speaker: Doctor D. Hofer (Zurich, CH)

History of pacing for SND patients: early pacing to modern solutions

Speaker: Doctor M. Biffi (Bologna, IT)

Is AAI leadless the ultimate physiologic pacing option for SND patients with normal AV conduction? The experience from an LBBAp implanter

Speaker: Professor A. Rinaldi (London, GB)

Access the full session

A new era in leadless pacing: a path to a new standard of care?

Speakers: Professor J. Kuschyk, Professor R. Knops, Doctor D. Hofer, Doctor M. Biffi, Professor A. Rinaldi

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources